Radiant Innovation

Radiant Innovation Equity Ratio

The Equity Ratio of Radiant Innovation (3373.TWO) as of Nov 2, 2026 is 92.16 %. In the previous year, Equity Ratio was 92.57 % — a change of -0.44% (lower).

Equity Ratio

92.16 %

YoY

-0.44%

Last updated:

Equity Ratio of Radiant Innovation is 2025 92.16 % . Equity Ratio of Radiant Innovation was 2024 92.57 % . It decreases by -0.44% lower compared to the previous year.

The Radiant Innovation Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
83.65 TWD
Jan 1, 2019
84.11 TWD
Jan 1, 2020
69.98 TWD
Jan 1, 2021
86.10 TWD
Jan 1, 2022
91.47 TWD
Jan 1, 2023
94.56 TWD
Jan 1, 2024
92.57 TWD
Jan 1, 2025
92.16 TWD
The Radiant Innovation Equity Ratio history
YEAREquity RatioYoY
92.16 %-0.44%
92.57 %-2.11%
94.56 %+3.38%
91.47 %+6.24%
86.10 %+23.04%
69.98 %-16.80%
84.11 %+0.55%
83.65 %+0.49%
83.24 %-0.91%
84.01 %+1.96%
82.39 %+1.59%
81.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Equity Ratio of Radiant Innovation is 92.16 % in 2025.

Equity Ratio of Radiant Innovation changed from 92.57 % to 92.16 %, representing a -0.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Radiant Innovation with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Radiant Innovation

All Key Metrics — Radiant Innovation